Stocks and Investing Stocks and Investing
Wed, May 29, 2019
Tue, May 28, 2019
Fri, May 24, 2019
Thu, May 23, 2019

Laura Chico Initiated (BIIB) at Hold and Held Target at $231 on, May 23rd, 2019


Published on 2024-10-26 13:54:01 - WOPRAI, Laura Chico
  Print publication without navigation


Laura Chico of Wedbush, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $231 on, May 23rd, 2019.

Laura has made no other calls on BIIB in the last 4 months.



There are 14 other peers that have a rating on BIIB. Out of the 14 peers that are also analyzing BIIB, 11 agree with Laura's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $245 on, Thursday, May 9th, 2019
  • Sumant Kulkarni of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $275 on, Friday, March 22nd, 2019
  • Carter Gould of "UBS" Downgraded from Strong Buy to Hold on, Friday, March 22nd, 2019
  • Robyn Karnauskas of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $230 on, Friday, March 22nd, 2019
  • Salim Syed of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $235 on, Friday, March 22nd, 2019
  • Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Alethia Young of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Matt Phipps of "William Blair" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Ian Somaiya of "BMO Capital" Initiated at Hold and Held Target at $322 on, Friday, February 22nd, 2019
  • Adnan Butt of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $325 on, Friday, February 22nd, 2019
  • Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019


These are the ratings of the 3 analyists that currently disagree with Laura


  • Evan Seigerman of "Credit Suisse" Initiated at Sell and Held Target at $198 on, Tuesday, May 21st, 2019
  • Christopher Marai of "Nomura" Maintained at Strong Buy with Decreased Target to $320 on, Friday, March 22nd, 2019
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Sell on, Friday, March 22nd, 2019
Contributing Sources